FDA Approves Cymbalta to Treat Fibromyalgia

The United States Food and Drug Administration has approved Cymbalta for the treatment/management of Fibromyalgia, making it the second medication on the market available for Fibromyalgia treatment (Lyrica was the first medication approved by the FDA for Fibromyalgia treatment).

Cymbalta is also approved for the treatment of Generalized Anxiety Disorder, depression, and peripheral neuropathy pain.

Common, non-serious side effects of Cymbalta include:

• Decreased sex drive, inability to experience an orgasm, or impotence
• Changes in weight
• Sore throat
• Constipation
• Increased anxiety or nervousness or increased sweating
• Dizziness, drowsiness, and/or headache
• Insomnia

You need to call your doctor immediately if you experience any of the following side effects while on Cymbalta:

• overactive reflexes, loss of coordination, hallucinations, restlessness, coma, or fainting
• Nausea, low fever, stomach pain, jaundice (yellowish eyes and/or skin), stools that are clay colored, or dark colored urine
• Nausea, diarrhea, vomiting, fever, and rapid heartbeat

Of course if you experience an allergic reaction to this medication including swelling of the tongue, lips, throat, or face, have difficulty breathing, and/or develop hives, you need to seek immediate medical attention.

To learn more about Cymbalta, please visit www.cymbalta.com.